Digital Health Startups

Enable Biosciences develops ultrasensitive antibody detection assays based on its Antibody Detection by Agglutination-PCR (ADAP) technology for diagnosing conditions including type 1 diabetes, celiac disease, food allergy, Lyme disease, and Zika/dengue. It offers testing services, custom assay development, and automated workstations for research and clinical diagnostics laboratories.

1 investor

Enable Dental provides mobile dental care by bringing portable dental systems directly to patients wherever they live, handling diagnosis and treatment on a recurring schedule. It manages scheduling, care coordination, and billing, and tailors dental service arrangements to an organization's needs and budget.

1 investor

Enable U (formerly Scamander) provides data management platform services and organizational change support to public sector and government organizations. The company helps municipalities and their partners centralize data, establish unified data models, and enable data-driven decision-making through standardized platform implementation and data governance consulting.

1 investor

A platform connecting caregivers and parents with licensed occupational therapists for online consultations and guidance. The service aims to make professional therapy accessible and convenient for families supporting children with various needs.

1 investor

Enatom develops digital learning solutions for anatomy education, combining visualization techniques and expertise in medical sciences. Based in the Netherlands, the company works with medical institutions to advance how anatomy is taught.

1 investor

This Is Perimenopause is a content and community initiative that shares personal stories, facts, and information to help women understand and navigate perimenopause and menopause. It aims to provide education, support, and advocacy around the hormonal transition and its 30-plus symptoms.

1 investor

Encultured is an AI company focused on applying artificial intelligence to healthcare, with the aim of using AI to care for and improve human health. It was founded by AI safety researchers seeking to steer AI technology in a positive direction, using healthcare as the primary application sector.

1 investor

Encyrcle provides an automated, text-based platform for substance use disorder and mental health treatment centers to manage post-discharge alumni engagement, compliance tracking, and relapse detection. The platform integrates with EMR systems and uses AI and NLP to identify at-risk clients, automate outreach workflows, and generate insights for value-based care models.

1 investor

EndoDNA + BIOS is a precision health intelligence platform for licensed healthcare practitioners that integrates genomic analysis, biomarkers, lifestyle data, and machine learning into a clinical decision-support system. The platform combines DNA sequencing with an AI reasoning engine to generate unlimited personalized wellness reports and treatment recommendations from a single patient DNA sample.

1 investor

EndoVia develops a precision oncology platform that combines experimental biology with computational modeling to match cannabinoid-based cancer treatments to individual patients. It maps cannabinoid and extract libraries against biological targets, uses subtype-specific tumor models and multi-omics profiling, and builds predictive network and digital-twin models to guide therapeutic development.

1 investor

Enhance-d is a free digital platform that brings together glucose data, workouts and wearable device data to give people who exercise with diabetes personalised insight around each training session. It also offers a Clinician Dashboard for healthcare professionals and coaches to view exercise in context with glucose data, and runs a global community for members.

1 investor

EnLite connects patients and their families with therapeutic companions, caregivers, psychologists, and psychiatric services, providing individualized treatment plans and daily progress reports. It also offers technical training courses in psychology and formation for therapeutic companions, while supporting its service providers through supervision, training, and benefits.

1 investor

Enov.one is a telehealth service offering personalized longevity and hormone optimization care, including bio-identical hormone balancing (for optimization, peri- and post-menopause) and pharmaceutical-grade medications and supplements such as B12, NAD+, and GSH. It uses an online assessment and AI, optionally combined with lab or DNA results, to connect patients with board-certified doctors and address conditions like fatigue, brain fog, mood imbalances, and weight management, serving 48 of 50 US states.

1 investor

EnrollNow is a software platform for managing participant screening, enrollment, and study management across academic, clinical, and independent research programs. Originating from a University of Michigan research lab and licensed through Ripple Science Corporation, it is used by research teams globally and is HIPAA-compliant and SOC 2 certified.

1 investor

Fundación INTRAS is a nonprofit organization running an R&D and innovation program that co-creates assistive and digital health technologies with end users, professionals, and the public for mental health, dementia, elderly care, and long-term social-health care. Its research covers areas such as AI, social robotics, virtual reality, and rehabilitation systems, with results transferred to market through its spin-off IDES.

1 investor

ENTvantage Dx develops rapid, in-office diagnostic tests for primary care physicians and otolaryngologists to identify the causes of ear, nose, and throat illnesses. The company operates in the in-vitro diagnostics sector serving the medical diagnostics industry.

1 investor

Entelai develops clinically validated artificial intelligence tools for medicine, including diagnostic support for neurological conditions such as multiple sclerosis and headache assessment via brain MRI analysis. It serves healthcare professionals, medical institutions and patients across Latin America, and also offers an online service for medical prescriptions and studies.

1 investor

Enterapia is an online mental health platform offering therapy with licensed psychologists through video sessions (Videoterapia) and text-based chat sessions (Chaterapia). It serves individuals seeking remote psychological support across multiple cities and countries in Spanish-speaking markets.

1 investor

enTouch (エンタッチ株式会社) provides remote-detailing products and services that help pharmaceutical and medical device makers communicate with healthcare professionals, including a scheduling/management platform and an outsourced MR (remote medical representative) service. Operating in Japan, it partners with Toho Holdings to secure appointments with doctors and pharmacists and deliver product information remotely.

1 investor

NextGen Mobile is a mobile EHR application for healthcare providers that integrates clinical AI capabilities including ambient listening, voice dictation, and automated note generation to reduce documentation time. The platform enables physicians and clinical staff to manage patient workflows, e-prescribe, and handle administrative tasks directly from mobile devices.

1 investor

Envisionit Deep AI builds RATIFY, a vendor-agnostic AI assurance platform for radiology that validates and monitors third-party healthcare AI tools in real time, tracking model drift, human–AI interaction, and performance. It serves hospitals and radiologists, integrating into existing PACS/RIS workflows to make clinical AI safety and performance measurable.

1 investor

Eodyne offers the RGS Ecosystem, an AI-based rehabilitation platform that supports neurorehabilitation and hip/knee replacement recovery across hospital, clinic, and home settings. It serves patients and rehabilitation professionals, aligning therapy with clinical guidelines to improve functional recovery and treatment adherence.

1 investor

Eon Health provides a platform for detecting and managing lung cancer early, helping healthcare systems identify and track pulmonary nodules to improve patient outcomes. The solution serves hospitals and healthcare networks seeking to improve early cancer detection through systematic care management.

1 investor

Eos BioInnovation invests in early-stage regenerative medicine therapies and technologies, focusing on cell, gene, and tissue therapies that target disease causes. The firm partners with researchers and entrepreneurs to accelerate the translation of breakthrough science into commercial biotech companies.

1 investor